Additional Information
Book Details
Abstract
In the fast-changing age of precision medicine, PET/CT is increasingly important for accurate cancer staging and evaluation of treatment response. Fundamentals of Oncologic PET/CT, by Dr. Gary A. Ulaner, offers an organized, systematic introduction to reading and interpreting PET/CT studies, ideal for radiology and nuclear medicine residents, practicing radiologists, medical oncologists, and radiation oncologists. Synthesizing eight years’ worth of cases and lectures from one of the largest cancer centers in the world, this title provides a real-world, practical approach, taking you through the body organ by organ as it explains how to integrate both the FDG PET and CT findings to best interpret each lesion.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | cover | ||
| IFC_ExCon page | IFC2 | ||
| Fundamentals of Oncologic PET/CT | i | ||
| Copyright Page | iv | ||
| Dedication | v | ||
| Preface | vii | ||
| Table Of Contents | ix | ||
| I Introduction and Fundamentals | 1 | ||
| 1 Introduction to FDG PET/CT | 1 | ||
| Abstract | 1.e1 | ||
| Keywords | 1.e1 | ||
| 2 FDG PET/CT Performance and Reporting | 5 | ||
| Abstract | 5.e1 | ||
| Keywords | 5.e1 | ||
| Performing FDG PET/CT | 5 | ||
| Quantifying FDG Avidity With Standardized Uptake Values | 5 | ||
| Reporting FDG PET/CT Examinations | 6 | ||
| Structured Reports | 6 | ||
| Conveying Diagnostic Certainty | 7 | ||
| PET Findings Versus CT Findings | 8 | ||
| Reference Lesions | 8 | ||
| Suggested Readings | 8 | ||
| II Musculoskeletal System and Body Wall | 9 | ||
| 3 Skeleton on FDG PET/CT | 9 | ||
| Abstract | 9.e1 | ||
| Keywords | 9.e1 | ||
| FDG-Avid Cancer | 9 | ||
| Metastases | 9 | ||
| Lymphoma | 9 | ||
| Multiple Myeloma | 10 | ||
| Primary Osseous Sarcomas | 10 | ||
| Not FDG Avid and Not Cancer | 12 | ||
| Not FDG Avid but Cancer | 14 | ||
| FDG Avid but Not Cancer | 14 | ||
| Granulocyte Colony-Stimulating Factors | 16 | ||
| Degenerative Changes | 17 | ||
| Inflammatory Diseases | 23 | ||
| Fractures | 23 | ||
| Bone Infarcts (Avascular Necrosis of Bone) | 24 | ||
| Paget Disease | 25 | ||
| Transient Osteoporosis of the Hip | 26 | ||
| Benign Neoplasms | 26 | ||
| Nonossifying Fibromas | 26 | ||
| Biopsy Tracts | 29 | ||
| Radiation-Induced Osteoradionecrosis | 30 | ||
| Conclusion | 32 | ||
| Suggested Readings | 32 | ||
| 4 Muscle and Nerve on FDG PET/CT | 33 | ||
| Abstract | 33.e1 | ||
| Keywords | 33.e1 | ||
| Conclusion | 41 | ||
| Suggested Readings | 42 | ||
| 5 Skin and Breast on FDG PET/CT | 43 | ||
| Abstract | 43.e1 | ||
| Keywords | 43.e1 | ||
| Suggested Readings | 50 | ||
| III Head and Neck | 51 | ||
| 6 Brain on FDG PET/CT | 51 | ||
| Abstract | 51.e1 | ||
| Keywords | 51.e1 | ||
| Normal Brain | 51 | ||
| Initial Detection of Brain Malignancy | 51 | ||
| Treatment Response of Brain Malignancy | 57 | ||
| Tumor Recurrence Versus Radiation Necrosis | 57 | ||
| Benign Intracranial Lesions | 58 | ||
| Infarcts and Seizures | 58 | ||
| Suggested Readings | 62 | ||
| 7 Head and Neck on FDG PET/CT | 63 | ||
| Abstract | 63.e1 | ||
| Keywords | 63.e1 | ||
| Head and Neck Anatomy | 63 | ||
| Physiology FDG Avidity in the Head and Neck | 66 | ||
| Anatomic and Metabolic Alterations by Surgery and Chemoradiation | 67 | ||
| Salivary Glands | 69 | ||
| Thyroid Gland | 69 | ||
| Vocal Cords | 74 | ||
| Squamous Cell Carcinomas | 74 | ||
| Lymphoma | 81 | ||
| Orbit | 82 | ||
| Perineural Disease | 83 | ||
| Concurrent Pathology | 83 | ||
| Suggested Readings | 85 | ||
| IV Thorax | 87 | ||
| 8 Lung on FDG PET/CT | 87 | ||
| Abstract | 87.e1 | ||
| Keywords | 87.e1 | ||
| Solitary Pulmonary Nodules | 87 | ||
| Multiple Pulmonary Nodules | 87 | ||
| Lung Cancer | 87 | ||
| Benign Lung Lesions With Distinct Appearances | 93 | ||
| Suggested Readings | 98 | ||
| 9 Pleura on FDG PET/CT | 99 | ||
| Abstract | 99.e1 | ||
| Keywords | 99.e1 | ||
| Postpleurodesis Inflammation | 99 | ||
| Pleural Metastases | 99 | ||
| Pleural Mesothelioma | 99 | ||
| Suggested Readings | 101 | ||
| 10 Heart on FDG PET/CT | 103 | ||
| Abstract | 103.e1 | ||
| Keywords | 103.e1 | ||
| Suggested Readings | 107 | ||
| 11 Thymus Masses on FDG PET/CT | 109 | ||
| Abstract | 109.e1 | ||
| Keywords | 109.e1 | ||
| Suggested Readings | 111 | ||
| V Abdominal Solid Organs | 113 | ||
| 12 Hepatobiliary FDG PET/CT | 113 | ||
| Abstract | 113.e1 | ||
| Keywords | 113.e1 | ||
| Liver | 113 | ||
| Hepatic Metastases | 113 | ||
| Lymphoma | 118 | ||
| Hepatocellular Carcinoma | 118 | ||
| Cholangiocarcinoma | 118 | ||
| Hepatocellular Adenoma | 119 | ||
| Hepatic Hemangioma | 121 | ||
| Hepatic Focal Nodular Hyperplasia | 121 | ||
| Hepatic Cysts | 122 | ||
| Hepatic Infections | 122 | ||
| Iatrogenic FDG Avidity in the Liver | 122 | ||
| Gallbladder | 122 | ||
| Gallbladder Cancer | 123 | ||
| Gallbladder Metastases | 124 | ||
| Cholecystitis | 124 | ||
| Suggested Readings | 126 | ||
| 13 Spleen on FDG PET/CT | 127 | ||
| Abstract | 127.e1 | ||
| Keywords | 127.e1 | ||
| Splenic Lymphoma | 127 | ||
| Splenic Metastases | 127 | ||
| Primary Splenic Neoplasms | 127 | ||
| Granulomatosis Inflammation | 127 | ||
| Splenic Repopulation | 129 | ||
| Suggested Readings | 131 | ||
| 14 Pancreas on FDG PET/CT | 133 | ||
| Abstract | 133.e1 | ||
| Keywords | 133.e1 | ||
| Solid Pancreatic Lesions | 133 | ||
| Pancreatic Adenocarcinoma | 133 | ||
| Pancreatic Neuroendocrine Tumors | 133 | ||
| Pancreatic Lymphoma | 135 | ||
| Pancreatic Metastases | 136 | ||
| Cystic Pancreatic Lesions | 136 | ||
| True Pancreatic Cysts | 136 | ||
| Pancreatic Pseudocysts | 136 | ||
| Pancreatic Cystic Neoplasms | 136 | ||
| Pancreatic Ductal Dilatation | 137 | ||
| Pancreatitis | 137 | ||
| Suggested Readings | 141 | ||
| 15 Adrenal Glands on FDG PET/CT | 143 | ||
| Abstract | 143.e1 | ||
| Keywords | 143.e1 | ||
| Adrenal Metastases | 143 | ||
| Adrenal Lymphoma | 143 | ||
| Adrenocortical Carcinoma | 143 | ||
| Adenoma | 143 | ||
| Adrenal Pheochromocytoma | 148 | ||
| Myelolipoma | 148 | ||
| Ganglioneuroma | 148 | ||
| Physiologic Adrenal FDG Avidity | 148 | ||
| Adrenal Hyperplasia | 148 | ||
| Infection, Hemorrhage, and Trauma | 149 | ||
| Adrenal Collision Tumors | 149 | ||
| Suggested Readings | 150 | ||
| VI Gastrointestinal Tract and Peritoneum | 151 | ||
| 16 Gastrointestinal Tract on FDG PET/CT | 151 | ||
| Abstract | 151.e1 | ||
| Keywords | 151.e1 | ||
| Esophagus | 151 | ||
| Stomach | 153 | ||
| Small Bowel | 157 | ||
| Appendix | 161 | ||
| Colorectal | 161 | ||
| Anus | 165 | ||
| Suggested Readings | 169 | ||
| 17 Peritoneum on FDG PET/CT | 171 | ||
| Abstract | 171.e1 | ||
| Keywords | 171.e1 | ||
| Peritoneal Metastases | 171 | ||
| Primary Peritoneal Malignancies | 171 | ||
| Benign Peritoneal Processes | 176 | ||
| Suggested Readings | 177 | ||
| VII Genitourinary | 179 | ||
| 18 Urinary Tract on FDG PET/CT (Kidneys, Ureters, Bladder) | 179 | ||
| Abstract | 179.e1 | ||
| Keywords | 179.e1 | ||
| Kidney | 179 | ||
| Renal Cell Carcinoma | 179 | ||
| Oncocytoma | 179 | ||
| Transitional Cell Carcinoma | 182 | ||
| Angiomyolipoma | 182 | ||
| Wilms Tumor | 182 | ||
| Renal Lymphoma | 182 | ||
| Renal Metastases | 184 | ||
| Renal Cysts | 184 | ||
| Renal Infections | 184 | ||
| Bladder | 186 | ||
| Bladder Cancer | 186 | ||
| Bladder Diverticula Versus Pericystic Nodes/Masses | 187 | ||
| Urachal Lesions | 187 | ||
| Suggested Readings | 190 | ||
| 19 Female Pelvis on FDG PET/CT | 191 | ||
| Abstract | 191.e1 | ||
| Keywords | 191.e1 | ||
| Physiologic FDG Avidity in the Female Reproductive Tract | 191 | ||
| Ovary | 191 | ||
| Ovarian Cancer | 191 | ||
| Benign Ovarian Lesions | 197 | ||
| Endometrium | 197 | ||
| Endometrial Cancer | 197 | ||
| Benign Endometrial FDG Avidity | 197 | ||
| Myometrium | 197 | ||
| Myometrial Leiomyomata | 197 | ||
| Myometrial Leiomyosarcoma | 200 | ||
| Cervix | 200 | ||
| Cervical Carcinoma | 200 | ||
| Suggested Readings | 203 | ||
| 20 Male Pelvis on FDG PET/CT | 205 | ||
| Abstract | 205.e1 | ||
| Keywords | 205.e1 | ||
| Testes | 205 | ||
| Physiologic FDG Avidity in the Testes | 205 | ||
| Testicular Malignancies | 205 | ||
| Orchitis | 205 | ||
| Prostate | 205 | ||
| Suggested Readings | 210 | ||
| VIII Additional Issues in FDG PET/CT | 211 | ||
| 21 Lymph Nodes on FDG PET/CT | 211 | ||
| Abstract | 211.e1 | ||
| Keywords | 211.e1 | ||
| Lymphoma | 211 | ||
| Nodal Metastases | 213 | ||
| Benign FDG-Avid Nodes | 213 | ||
| Suggested Readings | 223 | ||
| 22 Measuring Treatment Response on FDG PET/CT | 225 | ||
| Abstract | 225.e1 | ||
| Keywords | 225.e1 | ||
| Suggested Readings | 229 | ||
| 23 Artifacts on FDG PET/CT | 231 | ||
| Abstract | 231.e1 | ||
| Keywords | 231.e1 | ||
| Motion | 231 | ||
| Attenuation Correction Artifacts | 231 | ||
| Partial Volume Effect Artifacts | 231 | ||
| Biodistribution of FDG | 232 | ||
| “Blooming” Of Highly Concentrated FDG | 232 | ||
| Suggested Readings | 234 | ||
| IX Radiotracers Other Than FDG for Oncologic PET/CT | 235 | ||
| 24 Radiotracers Other Than FDG for Oncologic PET/CT | 235 | ||
| Abstract | 235.e1 | ||
| Keywords | 235.e1 | ||
| 18F-Sodium Fluoride (Na18F) | 235 | ||
| 68Ga-DOTATATE | 236 | ||
| 11C-Choline | 237 | ||
| Fluciclovine | 239 | ||
| 68Ga-PSMA-11 | 240 | ||
| Conclusion | 242 | ||
| Suggested Readings | 242 | ||
| Index | 243 | ||
| A | 243 | ||
| B | 243 | ||
| C | 243 | ||
| D | 244 | ||
| E | 244 | ||
| F | 244 | ||
| G | 244 | ||
| H | 245 | ||
| I | 245 | ||
| K | 245 | ||
| L | 245 | ||
| M | 246 | ||
| N | 246 | ||
| O | 246 | ||
| P | 246 | ||
| R | 247 | ||
| S | 247 | ||
| T | 248 | ||
| U | 248 | ||
| V | 248 | ||
| W | 248 | ||
| IBC_Clinical Key ad | IBC3 |